This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ong, A. T.L. Articles by Serruys, P. W. Search for Related Content PubMed PubMed Citation Articles by Ong, A. T.L. Articles by Serruys, P. W. Pubmed/NCBI databases Medline Plus Health Information Angioplasty Coronary Artery Bypass Surgery Related Collections Catheter-based coronary interventions: stents CV surgery: coronary artery disease Chronic ischemic heart disease

(Circulation. 2006;114:249-255.)
© 2006 American Heart Association, Inc.

Contemporary Reviews in Cardiovascular Medicine

Complete Revascularization

Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention

Andrew T.L. Ong, MBBS, FRACP; Patrick W. Serruys, MD, PhD

From the Department of Interventional Cardiology, Thoraxcentre, Erasmus Medical Centre, Rotterdam, the Netherlands.

Correspondence to Professor P.W. Serruys, MD, PhD, Thoraxcentre, Ba 583, Dr Molewaterplein 40, 3015-GD Rotterdam, The Netherlands. E-mail p.w.j.c.serruys@erasmusmc.nl

Key Words: angioplasty • bypass • occlusion • revascularization • surgery • stents

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
The concept of complete revascularization arose from the early studies on coronary artery bypass grafting (CABG) surgery whereby some publications demonstrated that patients who were completely revascularized enjoyed a mortality benefit over those who were incompletely revascularized, thus setting the standard for the field of CABG.^1–3 Over the past 3 decades, CABG has evolved from saphenous vein grafting to more frequent use of arterial grafting, better perioperative management, development of a less invasive approach, and off-pump surgery as a genuine option. The development of percutaneous coronary interventions (PCIs) for the treatment of coronary stenosis has developed out of the treatment of single-vessel disease to become an alternative to CABG in the treatment of multivessel disease.^4,5 PCI has progressed from balloon angioplasty to coronary stents,^6,7 and now drug-eluting stents,⁸ with the simultaneous development of new devices to treat chronic total occlusions (CTOs). For both groups of patients treated by either CAGB or PCI, there is recognition that aggressive pharmacological secondary-prevention therapies such as statins and antiplatelet agents are beneficial and are now commonly used.

Despite the mantra of complete revascularization, none of the current guidelines set out by the American or European cardiology societies formally discuss the issue in detail. Although this topic has been addressed separately within each revascularization strategy, to date there has been only 1 report from a randomized trial that compared the end point of complete revascularization between CABG and PCI.⁹ This review will therefore address the issue separately for CABG and for PCI and finally provide . . . [Full Text of this Article]

This article has been cited by other articles:

				E. L. Hannan, C. Wu, G. Walford, D. R. Holmes, R. H. Jones, S. Sharma, and S. B. King III Incomplete Revascularization in the Era of Drug-Eluting Stents: Impact on Adverse Outcomes J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 17 - 25. [Abstract] [Full Text] [PDF]

				D. M. Holzhey, S. Jacobs, M. Mochalski, D. Merk, T. Walther, F. W. Mohr, and V. Falk Minimally Invasive Hybrid Coronary Artery Revascularization Ann. Thorac. Surg., December 1, 2008; 86(6): 1856 - 1860. [Abstract] [Full Text] [PDF]

				E. Martuscelli, F. Clementi, M. M. Gallagher, A. D'Eliseo, G. Chiricolo, A. Nigri, B. Marino, F. Romeo, and on behalf of CABRI trialists Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded; data from the CABRI trial Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 4 - 8. [Abstract] [Full Text] [PDF]

				P. G. Camici, S. K. Prasad, and O. E. Rimoldi Stunning, Hibernation, and Assessment of Myocardial Viability Circulation, January 1, 2008; 117(1): 103 - 114. [Full Text] [PDF]